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Following the identification of two autochthonous 
cases of dengue type 1 on 3 October 2012, an out-
break of dengue fever has been reported in Madeira, 
Portugal. As of 25 November, 1,891 cases have been 
detected on the island where the vector Aedes aegypti 
had been established in some areas since 2005. This 
event represents the first epidemic of dengue fever 
in Europe since 1928 and concerted control measures 
have been initiated by local health authorities. 
On 3 October 2012, two autochthonous cases of den-
gue fever were laboratory confirmed in the Autonomous 
Region of Madeira (RAM), Portugal, following clinical 
suspicion of dengue, i.e. sudden onset of fever and 
influenza-like symptoms in patients without travel 
history to dengue-endemic regions. Laboratory tests 
performed by the National Institute of Health in Lisbon 
identified dengue virus serotype 1 (DENV-1) as causing 
agent. As of 25 November, the Institute of Health and 
Social Affairs (Instituto de Administração da Saúde e 
Assuntos Sociais, IASAUDE, RAM) in Madeira reported 
1,891 cases of dengue fever. In this preliminary report 
we highlight the main features of the outbreak and the 
control measures taken. 
Background
Dengue is a vector-borne disease caused by a flavivirus 
with four distinct serotypes (DEN-1-4). The most com-
petent mosquitoes species for disease transmission 
are Aedes aegypti (Linnaeus, 1762) and Ae. albopictus 
(Skuse, 1894) [1]. The last outbreak of dengue in Europe 
occurred in 1928, in Greece [2] but imported cases 
of dengue fever in travellers returning from endemic 
countries are often reported [2-6]. Additionally, spo-
radic autochthonous cases were recorded recently in 
areas of France and Croatia where Ae. albopictus is 
present [7,8]. 
Madeira is the main island of the Autonomous Region 
of Madeira, a Portuguese territory with 262,302 inhab-
itants [9]. It is located at around 1,000 km from main-
land Portugal and around 500 km from the northern 
African coast. The other inhabited island of the Region 
is Porto Santo with 5,483 inhabitants [9]. The climate 
is temperate Mediterranean, with little temperature 
variation throughout the year [10]. Ae. aegypti was first 
identified on Madeira in 2005, in Santa Luzia parish of 
Funchal city [11]. 
Epidemiological and clinical findings
After the detection of the first two autochthonous den-
gue fever cases on 3 October 2012, active case find-
ing was initiated and the following case definition has 
been used since:
A probable case should meet both clinical and epide-
miological criteria outlined hereafter.
Clinical criteria comprised acute onset of fever and at 
least two of the following symptoms and signs: head-
ache, retro-orbital pain, myalgia, arthralgia, exan-
thema, haemorrhagic manifestations or leucopoenia.
Epidemiological criteria are residing in or having vis-
ited a dengue-affected area during the 21 days prior 
to onset of symptoms. Currently, the whole island is 
considered as ‘affected area’ which means that the 
epidemiological criterion is met for all cases occurring 
on Madeira.
A confirmed case is defined as a probable case with at 
least one of the following laboratory results: (i) pres-
ence of dengue-virus-specific IgM antibodies in blood 
or cerebrospinal fluid (CSF); (ii) significant increase in 
the concentration of dengue-virus-specific IgG anti-
bodies (seroconversion), or; (iii) detection of dengue 
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virus nucleic acid in blood or CSF with RT-PCR or other 
Nucleic Acid Amplification Test (NAAT).
Pregnant women, patients with chronic diseases 
and with immunodeficiency were considered at par-
ticular risk of getting the disease and of possible 
complications.
As of 25 November 2012 (calendar week 47), seven 
weeks after the first autochthonous cases were identi-
fied, 1,891 probable cases of dengue fever have been 
reported, of which 966 were laboratory confirmed
Of the total number of 1,891 cases, 777 (41.1%) were 
male and 1,114 (58.9%) were female. The median age of 
the 1,891 cases was 39 years (range 25-64). Up to week 
47, the most affected age group was 25 to 64 years-old 
(Table).
One hundred and eleven patients were hospitalised 
and no fatalities were recorded. Of the total number of 
cases (n=1,891), the majority had mild symptoms, with 
fever, myalgia, headaches and arthralgia. 
Current geographic distribution of cumulative dengue 
cases by parish of residence is presented in Figure 2. 
The highest proportion of patients is recorded in resi-
dents of Santa Luzia parish. 
As of 25 November, 29 cases of dengue fever were 
reported among travellers returning from Madeira. 
Twelve cases of dengue fever were recorded in travel-
lers to mainland Portugal. In addition, 17 cases were 
detected in travellers returning to other European coun-
tries: United Kingdom (n=6), Germany (n=7), Sweden 
(n=1), France (n=2) and Finland (n=1).
Laboratory investigation 
Sequence analyses of viral genomes (600 nucleotides), 
performed at the National Institute of Health Dr. Ricardo 
Jorge, Lisbon, Portugal, presented high sequence simi-
larity with DEN-1 viruses circulating in Venezuela and 
Colombia, suggesting Latin America as the possible 
origin for the circulating dengue virus [12]. 
Entomological findings
In 2006, a mosquito surveillance system based on 
ovitraps, traps that collect eggs by mimicking breeding 
sites, was established to monitor the presence and the 
abundance of the vector on the island [13]. By 2009, Ae. 
aegypti was detected outside Funchal city in the neigh-
bouring localities of Câmara dos Lobos and Caniço. In 
September 2011, cross-sectional entomological sur-
veys were carried out using a total of 273 ovitraps dis-
persed throughout Madeira (253 ovitraps) and Porto 
Santo islands (20 ovitraps). Results showed that the 
mosquito population had expanded to the west (Ponta 
do Sol and Ribeira Brava counties) and east of Funchal 
city (Santa Cruz county). The vector was also detected 
in Porto Moniz, but its presence was not confirmed in 
subsequent monitoring activities (unpublished data).  
After the onset of the outbreak in October 2012, the 
surveillance network was reinforced and, currently, 
mosquito activity is monitored by 141 ovitraps and 16 
BG-sentinel traps, traps baited with attractants to bit-
ing females. These traps are distributed mainly along 
the south coast of the island and in selected areas 
such as harbours, the airport, healthcare facilities and 
potential transmission zones. Up to date the vector has 
not been found on Porto Santo. 
Control measures 
In response to the outbreak, several control meas-
ures have been undertaken by the health authorities 
of Madeira. In order to prevent exportation, enhanced 
vector control measures have been implemented at 
Madeira’s single airport. Currently, all aircrafts depart-
ing from the island undergo disinfestation procedures. 
Mosquito surveillance systems at the airport and at 
Figure 1
Notified dengue fever cases by week, Madeira, Portugal, 3 
October–25 November 2012 (n=1,891)
Source: Instituto de Administração da Saúde e Assuntos Sociais, 
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Notified dengue fever cases by age group, Madeira, 
Portugal, 3 October–25 November 2012 (n=1,891)







passenger and cargo harbours have been boosted. 
Particular care is being given to the passenger ship 
port, located in the most affected area, Funchal. 
Information, mainly focused on the use of personal pro-
tective measures and on the elimination of mosquito 
breeding sites [14], is being disseminated by several 
mechanisms: (i) individual information to residents 
through a door-to-door campaign carried-out by envi-
ronmental technicians of the IASAUDE, RAM; (ii) post-
ings on IASAUDE website and in traditional and social 
media, and; (iii) community-based activities involving 
the educational, religious and health sectors. Advice 
for travellers to Madeira has been issued, containing 
information about methods to reduce the risk of being 
bitten by mosquitoes and symptoms of the disease 
[15].
 Guidelines for diagnostic and management of den-
gue fever were provided to healthcare professionals. 
Measures to ensure blood safety and the safety of sub-
stances of human origin have been implemented and 
published since the detection of the first cases [16]. 
Nationwide measures to ensure blood safety in main-
land Portugal included deferral of potential blood 
donors who visited Madeira island for a period of 28 
days after leaving the affected area, deferral of poten-
tial blood donors with fever or influenza-like symptoms 
for 28 days after recovery, deferral of confirmed cases 
of dengue infection for 120 days after recovery and 
post transfusion haemovigilance.
Local measures applying to the blood services of the 
affected area included: (i) quarantine of all red cell 
concentrates resulting from blood collected during the 
previous 28 days and retrospective testing of relevant 
archived samples; (ii) deferral of blood donors with 
fever or influenza-like symptoms up to 28 days after 
recovery; (iii) deferral of confirmed dengue cases for 
120 days after diagnosis; (iv) laboratory screening of 
all blood donations by RT-PCR for dengue virus; (v) 
information to blood donors to report any symptoms 
in the 15 days after donation; (vi) stop of local platelet 
production and supply of platelets from the Portuguese 
Institute for Blood and Transplants (Instituto Português 
de Sangue e Transplantes – IPST). Special attention is 
paid to the optimal use of blood, appropriate manage-
ment of the blood supply and haemovigilance.
Discussion 
The 2012 dengue outbreak on Madeira is the first of 
its kind in Europe since 1928. Given its magnitude and 
Figure 2
Cumulative incidence of dengue cases by parish, outbreak on Madeira, Portugal, 3 October–25 November 2012
The map was created in Quantum GIS with support from the European Centre for Disease Prevention and Control.
no cases
Cumulative incidence per 10,000 inhabitants








its potential public health impact in a European con-
text, the European Centre for Disease Prevention and 
Control (ECDC) in Stockholm, Sweden, has, on request 
of the Portuguese authorities, deployed experts to 
Madeira to assist the regional and national authorities 
in investigating and controlling the outbreak and pre-
vent further expansion within Europe. 
While Ae. aegypti is not considered an established 
mosquito species in continental Europe, its presence 
has been sporadically reported in restricted areas in 
the Netherlands and Russia [17]. The present outbreak 
however, draws attention to the need to better assess 
the possibility of dengue epidemics mediated by Ae. 
albopictus, that is present in several European coun-
tries. Besides the need to reinforce strategies aimed at 
averting the introduction of Ae. aegypti in Europe [18], 
it is also important to detect and monitor all imported 
human cases that might introduce the virus among a 
very competent mosquito species, Ae. albopictus. 
At the time of publishing this report, the outbreak on 
Madeira is still ongoing. However, in week 48, the num-
ber of cases reported has decreased by around 54% 
(from 219 cases to 102 cases) when compared with the 
previous week. According to the weather forecast for 
the coming winter weeks, Madeira expects a decrease 
in temperature. This is assumed to have an impact on 
the vector, reducing its densities and, consequently, 
the number of dengue cases might further decline. 
Nevertheless, even in the absence of new reported 
human cases the virus may persist on the island either 
through vertical transmission or maintained by the 
small number of adult overwintering mosquito females. 
Given the challenges posed by the dengue outbreak 
on Madeira, continued vigilance and a coordinated 
regional, national and international approach are 
needed.
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